FarmSirma Soteks, ZAO ,   Russia

The tablets of the prolonged action covered with a cover, 35 mg.

Tablets 500 mg.

Lyophilizate for the preparation of a solution for intravenous administration, 1 mg.

Solvent for the preparation of dosage forms for injection.

Solution for intravenous administration 50 mg / ml and 100 mg / ml.

A solution for intravenous and subcutaneous administration of 5000 IU / ml.

Solution for intravenous and intramuscular injection 30 mg / ml.

Solution for intravenous and parabulbar injection 100 mg / ml.

Solution for intravenous and intramuscular injection, 2.5 mg / ml + 100 mg / ml.

Film-coated tablets.

Film-coated tablets.

Solution for intravenous administration of 20 mg / ml.

5 ml per ampoule of light-protective or colorless glass.

For 5 ampoules in a contoured cell package with a lid integral of a film of PVC or without a lid.

1 contour pack together with instructions for use in a pack of cardboard.

3 ampoules in a contoured cell pack of a polyvinyl chloride or polyethylene terephthalate film or a polystyrene tape.

1, 2 or 8 contour mesh packages together with instructions for use in a pack of cardboard.

5 ml in bottles of colorless glass, sealed with rubber stoppers and crimped with aluminum caps, equipped with plastic caps with an inscription in English "FLIP OFF" or without an inscription.

1 bottle with instructions for use in a pack of cardboard.

3 or 5 bottles in a cardboard stand together with instructions for use in a pack of cardboard.

Concentrate for solution preparation for infusions of 25 mg / ml.

Solution for intravenous and intramuscular injection, 125 mg / ml and 250 mg / ml.

Solution for oral administration, 100 mg / ml.

Solution for intravenous and intramuscular injection, 50 mg / ml.

Granules for the preparation of a suspension for Ingestion 100 mg.

2 grams of granules in a laminated bag from a three-layer foil (polyethylene, aluminum, paper).

By 2,4,6,10, 20 or 30 bags together with instructions for use in a pack of cardboard.

Solution for infusion and subcutaneous administration, 0.1 mg / ml.

Solution for intravenous and intramuscular injection 4 mg / 2 ml or 8 mg / 4 ml (2 mg / ml).

Concentrate for solution for infusion, 500 mg / ml.

Solution for intravenous administration 10 mg / ml.

Solution for intraarticular administration 10 mg / ml.

2 ml in syringes of colorless neutral glass without a needle, with a protective plug and

with or without a cap an additional cap, or

additional cap with control first autopsy.

1 syringe per contour packing from polyvinylchloride film

or a film of polyethylene terephthalate and films of a multilayer polymer or

polypropylene films, or films polyethylene, or paper packaging with

polymer coating, or paper for packaging of medical products,

aluminum foil or in a bag of paper and films.

1 contour cell package or package with instructions for use in

pack of cardboard.

Solution for intramuscular injection 200 mg / ml complete with a solvent.

Solution for intravenous and intramuscular injection 50 mg / ml.

A solution for intravenous and intramuscular administration of 20 mg / ml.

Solution for oral administration, 600 mg / 5 ml.

Solution for injection 10,000 anti-Xa ME (100 mg) / ml.

The solution for intravenous and subcutaneous administration is 40,000 IU / ml.

Solution for intravenous and subcutaneous administration 3000 ME, 5000 ME or 20 000 ME.

Solution for injection, 125 mg / ml.